已收盤 10-31 16:00:00 美东时间
0.000
0.00%
Nautilus Biotechnology, Weill Cornell Medicine-Qatar, and The Michael J. Fox Foundation are collaborating to study alpha-synuclein's role in Parkinson's disease, supported by a $1.6 million MJFF grant. The project aims to develop a single-molecule assay to measure alpha-synuclein proteoforms, improving understanding of disease biology and biomarker development. This interdisciplinary effort combines Nautilus' Iterative Mapping method and WCM-Q's ...
01-28 13:00
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
2024-10-14 07:10
Nautilus Biotechnology Inc:杰富瑞假设保额为持仓与买入评级;目标股价为3美元兑5美元
2024-06-03 14:12
Nautilus (NYSE:NLS) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.44) by 65.91 percent. This is a 85.85 percent increase over losses of $(1.06) per share from the same
2023-08-10 04:59
New identity reflects the home fitness leader's commitment to helping consumers build a lifetime love of movement It's an inviting evolution of an iconic brand: Nautilus, Inc. (NYSE:NLS) is relaunching the
2023-07-31 20:33
Nautilus, Inc. (NYSE:NLS) (the "Company"), today announced that it has entered into a definitive securities purchase agreement with a certain institutional investor for the purchase and sale of 4,098,362 shares of the
2023-06-15 20:36
Nautilus (NYSE:NLS) reported its Q4 earnings results on Tuesday, May 23, 2023 a...
2023-05-24 04:35
Companies Reporting Before The Bell • ATRenew (NYSE:RERE) is estimated to report quarterly earnings at $0.03 per share on revenue of $405.22 million.
2023-05-23 18:58
Nautilus (NYSE:NLS) is set to give its latest quarterly earnings report on Tues...
2023-05-23 00:00
Nautilus, Inc. (NYSE:NLS – Get Rating) has received a consensus rating of "Hold...
2023-04-05 17:51